Results 31 to 40 of about 16,479 (221)

Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report

Indian Dermatology Online Journal, 2011
Although carbamazepine is the most common cause of Stevens Johnson syndrome (SJS) a new antiepileptic drug, oxcarbazepine which is structurally related to carbamazepine, has also been rarely shown to induce SJS.
S R Sharma, Nalini Sharma, M E Yeolekar
doaj   +1 more source

Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy

Frontiers in Neurology, 2023
ObjectiveWe evaluate the effect of distinct clinical features on anti-seizure medication (ASM) doses in seizure-free and not seizure-free patients aged ≥16 years with new-onset epilepsy.Materials and methodsThis study included 459 patients with a ...
Hire Hersi, Hire Hersi, Jukka Peltola, Jukka Peltola, Jani Raitanen, Jukka T. Saarinen   +5 more
doaj   +1 more source

Oxcarbazepine

Reactions Weekly
Preuss CV, Randhawa G, Saadabadi A.
europepmc   +2 more sources

Oxcarbazepine-induced Stevens-Johnson Syndrome: A Case Report

Kaohsiung Journal of Medical Sciences, 2009
Although carbamazepine (CBZ) is the most common cause of Stevens-Johnson syndrome (SJS), a new anticonvulsant, oxcarbazepine, which is structurally related to carbamazepine, has been shown to induce SJS, although extremely rarely.
Lung-Chang Lin, Ping-Chin Lai, Sheau-Fang Yang, Rei-Cheng Yang   +3 more
doaj   +1 more source

Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review

Journal of International Medical Research, 2018
Background Reversible splenial lesion syndrome is a distinct entity radiologically characterized by a reversible lesion in the splenium of the corpus callosum. According to previous reports, this condition may be associated with antiepileptic drug use or
Chaoyang Jing, Lichao Sun, Zhuo Wang, Chaojia Chu, Weihong Lin   +4 more
doaj   +1 more source

Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control

BMC Gastroenterology, 2018
Background Peripheral neuropathy is one most common, limiting and invalidating neurological symptom in subjects with hepatitis C virus and mixed cryoglobulinemia.
Rita Moretti, Paola Caruso, Matteo Dal Ben, Silvia Gazzin, Claudio Tiribelli   +4 more
doaj   +1 more source

The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders [PDF]

, 2014
Aggressive symptomatology presents across multiple psychiatric, developmental, neurological and behavioral disorders, complicating the diagnosis and treatment of the underlying pathology.
Ducharme, Peter, Gonzalez-Heydrich, Joseph, Guild, Danielle J., Munshi, Kaizad R., Oken, Tanya, Trivedi, Harsh K., Wang, Betty C.   +6 more
core   +1 more source

Challenges recruiting to a proof-of-concept pharmaceutical trial for a rare disease: The trigeminal neuralgia experience [PDF]

, 2018
Background: This study aimed to describe recruitment challenges encountered during a phase IIa study of vixotrigine, a state and use-dependent Nav1.7 channel blocker, in individuals with trigeminal neuralgia.
Bendtsen, Lars, Cruccu, Giorgio, Di Stefano, Giulia, Ettlin, Dominik A., Maarbjerg, Stine, Morisset, Valerie, Obermann, Mark, Palmer, Joanne, Steiner, Deb, Tate, Simon, Zakrzewska, Joanna M.   +10 more
core   +4 more sources

Systems Pharmacology [PDF]

, 2008
The slides are from a presentation given by Professor Ravi Iyengar from Mount Sinai School of Medicine at the Drug Forum Meeting #9 that took place in Washington, DC on February 20-21, 2008.
Ravi Iyengar
core   +2 more sources

Oxcarbazepine Monotherapy

Pediatric Neurology Briefs, 2006
The efficacy of oxcarbazepine monotherapy in 60 children and adolescents (aged 6 months to 17.8 years; mean age 8.2 yrs) with partial onset epilepsy was evaluated by retrospective chart review in a study at St Christopher’s Hospital for Children ...
J Gordon Millichap
doaj   +1 more source